CIK: 0001600135
Total reported value
$1.1B
Reporting period: 2015-09-30 · Number of holdings: 5
Third Rock Ventures, LLC disclosed 5 holdings in its latest 13F filing for the period ending 2015-09-30, with total reported value of $1.1B and a quarterly turnover rate of 100.0%.
Browse other institutions with $1B to $10B AUMBrowse other institutions starting with "T"
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Trim SG7
-26.6% -$367.8M
Trim ZFGNUSD
-93.4% -$104.2M
Trim 2655787D
0.0% -$38.1M
Trim 286221106
0.0% -$2.0M
New buy GBTUSD
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GBTUSD | Global Blood Therapeutics In | Stock-Other | 58.10% | +58.10% | NEW | |
| 2 | SG7 | Sage Therapeutics INC | Stock-Other | 25.46% | -41.20% | -26.56% | |
| 3 | 2655787D | Blueprint Medicines CORP | Stock-Other | 14.73% | -5.65% | — | |
| 4 | ✓ | Eleven Biotherapeutics INC | Stock-Other | 1.09% | -0.33% | — | |
| 5 | ZFGNUSD | Zafgen INC | Stock-Other | 0.63% | -10.91% | -93.43% |
Not enough priced holdings yet to compute performance
Not enough sector-mapped data yet
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2015-09-30 | 5 | $1.1B | 100 | |
| 2015-06-30 | 4 | $960.8M | 70 | |
| 2015-03-31 | 4 | $937.6M | 62 | |
| 2014-12-31 | 6 | $1.2B | 35 | |
| 2014-09-30 | 6 | $857.3M | 89 | |
| 2014-06-30 | 4 | $468.3M | 33 | |
| 2014-03-31 | 4 | $564.0M | 56 | |
| 2013-12-31 | 3 | $353.0M | 0 |
Third Rock Ventures, LLC's most significant position changes for 2015-09-30: New buy: Global Blood Therapeutics In (GBTUSD); Trim: Sage Therapeutics INC (SG7) — shares -26.56%; Trim: Zafgen INC (ZFGNUSD) — shares -93.43%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Eleven Biotherapeutics INC | -0.3% | — | Unchanged |
| 2 | 2655787D | Blueprint Medicines CORP | -5.7% | — | Unchanged |
| 3 | ZFGNUSD | Zafgen INC | -10.9% | -93.43% | Trim |
| 4 | SG7 | Sage Therapeutics INC | -41.2% | -26.56% | Trim |
| 5 | GBTUSD | Global Blood Therapeutics In | — | NEW | New buy |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2015-09-30 | 2015-11-03 | 13F-HR | View on EDGAR |
| 2015-06-30 | 2015-07-30 | 13F-HR | View on EDGAR |
| 2015-03-31 | 2015-04-29 | 13F-HR | View on EDGAR |
| 2014-12-31 | 2015-01-26 | 13F-HR | View on EDGAR |
| 2014-09-30 | 2014-10-22 | 13F-HR | View on EDGAR |
| 2014-06-30 | 2014-07-30 | 13F-HR | View on EDGAR |
| 2014-03-31 | 2014-04-30 | 13F-HR | View on EDGAR |
| 2013-12-31 | 2014-02-14 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001434997
Total reported value
$1.1B
88 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001759803
Total reported value
$1.1B
203 stks
2026-06-30
AUM within 0.0% of this institution
CIK 0001905809
Total reported value
$1.1B
15 stks
2026-03-31
AUM within 0.2% of this institution
Institutions with overlapping top holdings
CIK 0000924223
Total reported value
$4.0B
35 stks
2019-03-31
Stale — no recent filing
1 of the top 5 holdings overlap, including Sage Therapeutics INC
CIK 0001503559
Total reported value
$381.8M
3 stks
2016-03-31
Stale — no recent filing
1 of the top 5 holdings overlap
CIK 0001508051
Total reported value
$584.9M
5 stks
2016-06-30
Stale — no recent filing
1 of the top 5 holdings overlap